Scarica l'app Stockscreener
4.72
0.84%
-0.04
Dopo l'orario di chiusura:
4.72
Precedente Chiudi:
$4.76
Aprire:
$4.78
Volume 24 ore:
365.60K
Relative Volume:
0.57
Capitalizzazione di mercato:
$221.56M
Reddito:
$138.90M
Utile/perdita netta:
$-107.15M
Rapporto P/E:
-1.8706
EPS:
-2.5232
Flusso di cassa netto:
$-79.85M
1 W Prestazione:
-6.72%
1M Prestazione:
-17.77%
6M Prestazione:
-1.87%
1 anno Prestazione:
-33.61%
Intervallo 1D:
$4.60
$4.85
Intervallo di 1 settimana:
$4.60
$5.28
Portata 52W:
$4.05
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Nome
Quanterix Corp
Settore
Industria
Telefono
617-301-9400
Indirizzo
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
4.72 | 223.43M | 138.90M | -107.15M | -79.85M | -2.5232 |
|
ABT
Abbott Laboratories
|
108.03 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Iniziato | Scotiabank | Sector Outperform |
| 2023-09-25 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-15 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-08-09 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Aggiornamento | Goldman | Sell → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-04 | Iniziato | Goldman | Sell |
Mostra tutto
Quanterix Corp Borsa (QTRX) Ultime notizie
Risk Report: Whats the MACD signal for Quanterix CorporationRate Cut & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com
Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com
William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Quanterix Q4 Earnings Call Highlights - Defense World
Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st
Quanterix (QTRX) Q4 2025 Earnings Call Transcript - AOL.com
Quanterix Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus
Quanterix Q4 2025 Earnings Call Transcript - MarketBeat
Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Exceeds Q4 Revenue Expectations with Strong Per - GuruFocus
Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative
Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Quanterix Corporation 8-K Filing Analysis - TradingView
Quanterix Earnings Report: Q4 Overview - Benzinga
Alzheimer’s blood test heads to 15,000 community events a year - Stock Titan
Quanterix (QTRX) Set to Announce Q4 Earnings with Revenue Growth Expected - GuruFocus
Quanterix (QTRX) to Release Earnings on Monday - Defense World
Quanterix Corp expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Earnings Outlook For Quanterix - Benzinga
Quanterix Corp (QTRX) Q4 2025 Earnings Report Preview: What To L - GuruFocus
Quanterix to Participate in Upcoming Investor Conferences - ChartMill
Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX - Defense World
Biomarker firm Quanterix plans two March investor webcasts - Stock Titan
QTRX Should I Buy - Intellectia AI
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Investors can hear Quanterix 2025 results discussed on Mar. 2 call - Stock Titan
Quanterix (NASDAQ:QTRX) Shares Up 0.7%Time to Buy? - MarketBeat
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test - Clinical Lab Products
With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing - Yahoo Finance
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN
Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView
Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus
Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com
Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan
What’s the MACD signal for Quanterix CorporationWeekly Volume Report & Long-Term Growth Stock Strategies - mfd.ru
Quanterix (NASDAQ:QTRX) Trading Down 3.6%Here's What Happened - MarketBeat
Quanterix (NASDAQ:QTRX) Trading Down 3.6% – Here’s What Happened - Defense World
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Study finds multi-biomarker approach improves Alzheimer’s risk assessment - Investing.com
15-year brain study: blood test combo better flags Alzheimer’s risk - Stock Titan
Quanterix Corp Azioni (QTRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quanterix Corp Azioni (QTRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WALT DAVID R | Director |
Jun 13 '25 |
Buy |
6.14 |
123,990 |
760,803 |
1,866,933 |
| WALT DAVID R | Director |
Jun 12 '25 |
Buy |
6.23 |
36,010 |
224,166 |
1,742,943 |
| Toloue Masoud | President & CEO |
Jun 09 '25 |
Buy |
5.42 |
45,900 |
248,723 |
518,922 |
| WALT DAVID R | Director |
Jun 06 '25 |
Buy |
5.43 |
131,869 |
716,576 |
1,628,802 |
| WALT DAVID R | Director |
Jun 09 '25 |
Buy |
5.34 |
78,131 |
417,220 |
1,706,933 |
| DONNELLY WILLIAM P | Director |
Jun 06 '25 |
Buy |
5.44 |
93,113 |
506,348 |
139,094 |
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):